Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 18051-18100 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT03045029
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
N/A
Active, not recruiting
300 participants
Started: Jul 18, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
41 locations
NCT03115983
LimiFlex Clinical Trial for the Treatment of Degenerative Spondylolisthesis With Spinal Stenosis
NA
Active, not recruiting
299 participants
Started: Jul 17, 2017 · Completed: Jan 16, 2026
2 conditions
4 sponsors
28 locations
NCT03193281
KISS Study: Kinase Inhibition With Sprycel Start up
PHASE2
Active, not recruiting
91 participants
Started: Jul 17, 2017 · Completed: Dec 31, 2025
1 condition
2 sponsors
9 locations
NCT02987387
COMPASSION XT PAS - Post-approval Study of the SAPIEN XT THV in Patients With Pulmonary Valve Dysfunction
N/A
Active, not recruiting
57 participants
Started: Jul 17, 2017 · Completed: Sep 30, 2025
6 conditions
1 sponsor
12 locations
NCT03131908
Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss
PHASE1/PHASE2
Active, not recruiting
27 participants
Started: Jul 17, 2017 · Completed: Dec 31, 2025
2 conditions
5 sponsors
1 location
NCT03153202
Study to Evaluate the Safety and Preliminary Efficacy of Ibrutinib and Pembrolizumab in Patients With Chronic Lymphocytic Leukemia (CLL) or Mantle Cell Lymphoma (MCL)
PHASE1/PHASE2
Active, not recruiting
23 participants
Started: Jul 14, 2017 · Completed: Nov 30, 2026
2 conditions
2 sponsors
1 location
NCT04136392
The Global cVAD Study
N/A
Active, not recruiting
20,000 participants
Started: Jul 14, 2017 · Completed: Jan 31, 2026
1 condition
3 sponsors
51 locations
NCT03799107
Developmental Epidemiological Study of Children Born Through Reproductive Technology
N/A
Active, not recruiting
3,700 participants
Started: Jul 14, 2017 · Completed: Jul 1, 2025
6 conditions
2 sponsors
1 location
NCT03218761
POTS NET mRNA Functional Correlation With NET Activity
N/A
Active, not recruiting
200 participants
Started: Jul 14, 2017 · Completed: Dec 31, 2029
1 condition
3 sponsors
1 location
NCT03265431
Evaluation of PET/MR in Patients Selected for Ablation Therapy
PHASE2
Active, not recruiting
34 participants
Started: Jul 14, 2017 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT02650986
Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1
PHASE1/PHASE2
Active, not recruiting
15 participants
Started: Jul 14, 2017 · Completed: Jul 14, 2032
50 conditions
2 sponsors
1 location
NCT03334500
Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Prostate Cancer
EARLY_PHASE1
Active, not recruiting
30 participants
Started: Jul 14, 2017 · Completed: Jul 16, 2026
1 condition
1 sponsor
1 location
NCT03173703
Evaluate Safety and Effectiveness of XenoSure® Biological Patch in the Application of Peripheral Vascular Repair
NA
Active, not recruiting
144 participants
Started: Jul 13, 2017 · Completed: Nov 15, 2025
1 condition
1 sponsor
1 location
NCT03220646
Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors
PHASE2
Active, not recruiting
64 participants
Started: Jul 13, 2017 · Completed: Jul 31, 2026
1 condition
2 sponsors
8 locations
NCT03155997
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
PHASE3
Active, not recruiting
5,637 participants
Started: Jul 12, 2017 · Completed: May 31, 2029
1 condition
2 sponsors
619 locations
NCT03735797
Cancer Stem Cells in Acute Leukemia
N/A
Active, not recruiting
50 participants
Started: Jul 12, 2017 · Completed: Mar 1, 2026
1 condition
1 sponsor
2 locations
NCT03042104
EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis
NA
Active, not recruiting
901 participants
Started: Jul 12, 2017 · Completed: Mar 31, 2032
2 conditions
1 sponsor
77 locations
NCT03169985
Randomized Controlled Trial of Moderate-Intensity Rosuvastatin With Ezetimibe Combination Therapy Versus High-Intensity Rosuvastatin on Progression of Coronary Atherosclerotic Plaque
PHASE4
Active, not recruiting
280 participants
Started: Jul 12, 2017 · Completed: Jan 28, 2027
1 condition
2 sponsors
1 location
NCT03044613
Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer
PHASE1
Active, not recruiting
32 participants
Started: Jul 11, 2017 · Completed: Aug 31, 2027
3 conditions
2 sponsors
3 locations
NCT03633201
Anatomic Congruent Prosthetic Knee Design
NA
Active, not recruiting
75 participants
Started: Jul 11, 2017 · Completed: Sep 1, 2026
1 condition
2 sponsors
1 location
NCT03169075
QUALIOR Feasibility and Efficacy of a Supervised Home-based Standard Physical Exercise Program
NA
Active, not recruiting
190 participants
Started: Jul 11, 2017 · Completed: Jul 11, 2028
2 conditions
2 sponsors
15 locations
NCT03086421
Social Emotional Development in Young Children With Cancer
N/A
Active, not recruiting
119 participants
Started: Jul 11, 2017 · Completed: Jun 30, 2028
2 conditions
2 sponsors
1 location
NCT03217188
Proton Re-Irradiation for Recurrent Head and Neck Cancer
PHASE2
Active, not recruiting
87 participants
Started: Jul 10, 2017 · Completed: Jul 31, 2026
1 condition
1 sponsor
9 locations
NCT02682147
Functional CT Assessment of Pulmonary Arterial Dysfunction in Smoking Associated Emphysema
PHASE4
Active, not recruiting
17 participants
Started: Jul 10, 2017 · Completed: May 31, 2025
1 condition
3 sponsors
1 location
NCT03115086
The REPLACE Registry for Cholbam® (Cholic Acid)
N/A
Active, not recruiting
55 participants
Started: Jul 10, 2017 · Completed: Jul 31, 2039
1 condition
1 sponsor
23 locations
NCT03113929
Quantitative MRI for Non-invasive Assessment of Severity of Alcoholic Liver Disease (ALD)
N/A
Active, not recruiting
20 participants
Started: Jul 10, 2017 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT03213977
R-DA-EDOCH Versus R-CEOP90, With/Without Upfront Auto-HSCT in Young Patients With High-risk DLBCL
PHASE3
Active, not recruiting
475 participants
Started: Jul 10, 2017 · Completed: Jul 13, 2024
1 condition
1 sponsor
1 location
NCT03753334
Effects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer.
PHASE2
Active, not recruiting
39 participants
Started: Jul 10, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03219502
rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin Chemotherapy
NA
Active, not recruiting
56 participants
Started: Jul 10, 2017 · Completed: Apr 30, 2027
2 conditions
2 sponsors
1 location
NCT02969837
Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma
PHASE2
Active, not recruiting
46 participants
Started: Jul 10, 2017 · Completed: Mar 1, 2027
1 condition
4 sponsors
3 locations
NCT03215095
RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers
EARLY_PHASE1
Active, not recruiting
11 participants
Started: Jul 10, 2017 · Completed: Jul 31, 2026
1 condition
3 sponsors
7 locations
NCT03171025
Adjuvant Nivolumab Following Chemo-Radiation in Localized Muscle-Invasive Bladder Cancer
PHASE2
Active, not recruiting
200 participants
Started: Jul 10, 2017 · Completed: Oct 31, 2027
1 condition
2 sponsors
2 locations
NCT02860000
Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer
PHASE2
Active, not recruiting
96 participants
Started: Jul 6, 2017 · Completed: Dec 31, 2026
9 conditions
2 sponsors
8 locations
NCT03171311
The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER)
NA
Active, not recruiting
1,201 participants
Started: Jul 5, 2017 · Completed: May 31, 2029
2 conditions
2 sponsors
38 locations
NCT03184922
Fixed Versus Adjustable Loop in ACL Reconstruction
NA
Active, not recruiting
165 participants
Started: Jul 5, 2017 · Completed: Jan 31, 2026
1 condition
2 sponsors
1 location
NCT03194893
A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer
PHASE3
Active, not recruiting
200 participants
Started: Jul 5, 2017 · Completed: Oct 31, 2025
1 condition
1 sponsor
29 locations
NCT03040973
Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone
PHASE2
Active, not recruiting
29 participants
Started: Jul 4, 2017 · Completed: Jul 30, 2027
1 condition
1 sponsor
15 locations
NCT02905318
Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer
PHASE2
Active, not recruiting
19 participants
Started: Jul 4, 2017 · Completed: Dec 30, 2025
1 condition
2 sponsors
7 locations
NCT02911142
Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma
PHASE1/PHASE2
Active, not recruiting
17 participants
Started: Jul 3, 2017 · Completed: Oct 1, 2027
2 conditions
1 sponsor
1 location
NCT03405116
Prediction Tool for Premature Labour and Neonatal Outcome
N/A
Active, not recruiting
2,037 participants
Started: Jul 1, 2017 · Completed: Dec 31, 2032
1 condition
1 sponsor
1 location
NCT03607370
Timing for Rectal Surgery After Chemoradiotherapy
NA
Active, not recruiting
142 participants
Started: Jul 1, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04032860
RCT of Different Effects of Nucleot(s)Ide Analogues on the Prognosis of HBV-HCC Patients After Curative Resection
PHASE4
Active, not recruiting
104 participants
Started: Jul 1, 2017 · Completed: Jul 1, 2026
2 conditions
1 sponsor
1 location
NCT03199274
Perflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver Cancer
PHASE2
Active, not recruiting
104 participants
Started: Jul 1, 2017 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT06194370
The Application of BOPPPS(Bridge-in,Objective,Pre-assessment,Participatory Learning,Post-assessment,Summary) Model in the Ward Rounds of Nurses' Standardized Training
NA
Active, not recruiting
200 participants
Started: Jul 1, 2017 · Completed: Jan 31, 2024
1 condition
1 sponsor
1 location
NCT03329170
Improved Oral Health and Dental Care in Children with Congenital Heart Disease
NA
Active, not recruiting
150 participants
Started: Jul 1, 2017 · Completed: Dec 31, 2030
2 conditions
1 sponsor
1 location
NCT05706363
Comparison of Two Graft Choices in Mediale Patellofemoral Ligament Reconstruction (MPFL)
NA
Active, not recruiting
90 participants
Started: Jul 1, 2017 · Completed: Jul 30, 2026
1 condition
1 sponsor
1 location
NCT02994459
Study of Fat Tissue's Ability to Take up Sugar in the Obese Population
N/A
Active, not recruiting
90 participants
Started: Jul 1, 2017 · Completed: Jan 31, 2027
1 condition
1 sponsor
1 location
NCT03253172
Potassium Supplementation in CKD
NA
Active, not recruiting
532 participants
Started: Jul 1, 2017 · Completed: Oct 1, 2026
4 conditions
5 sponsors
4 locations
NCT04881617
Treatment for Speech and Language in Primary Progressive Aphasia
NA
Active, not recruiting
60 participants
Started: Jul 1, 2017 · Completed: Jun 30, 2024
7 conditions
3 sponsors
2 locations
NCT06649591
Expert Consensus and Artificial Intelligence in Medical Decision Making in Patients with Malignant Brain Tumors
N/A
Active, not recruiting
225 participants
Started: Jul 1, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
Previous
1
More pages
359
360
361
362
363
364
365
More pages
431
Next